News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,474 Results
Type
Article (87470)
Company Profile (806)
Press Release (773176)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233068)
Career Advice (4140)
Deals (39800)
Drug Delivery (138)
Drug Development (91261)
Employer Resources (203)
FDA (18287)
Job Trends (17403)
News (397428)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (126)
Alliances (56980)
ALS (147)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (256)
Approvals (18317)
Artificial intelligence (499)
Autoimmune disease (80)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (485)
Bladder cancer (135)
Brain cancer (53)
Breast cancer (514)
Cancer (4032)
Cardiovascular disease (343)
Career advice (3560)
Career pathing (38)
CAR-T (248)
CDC (57)
Cell therapy (690)
Cervical cancer (33)
Clinical research (75608)
Collaboration (1407)
Company closure (4)
Compensation (940)
Complete response letters (60)
COVID-19 (2960)
CRISPR (81)
C-suite (600)
Cystic fibrosis (139)
Data (4605)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (455)
Diagnostics (7095)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (238)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (204)
Earnings (98899)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133111)
Executive appointments (994)
FDA (20790)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1271)
Gene editing (173)
Generative AI (50)
Gene therapy (550)
GLP-1 (1023)
Government (5386)
Grass and pollen (7)
Guidances (351)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (245)
Immuno-oncology (21)
Indications (53)
Infectious disease (3207)
Inflammatory bowel disease (188)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (192)
Interviews (816)
IPO (17927)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (580)
Lymphoma (268)
Machine learning (31)
Management (66)
Manufacturing (646)
MASH (141)
Medical device (14882)
Medtech (14907)
Mergers & acquisitions (22757)
Metabolic disorders (1164)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (233)
Neuropsychiatric disorders (62)
Neuroscience (2732)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (563)
Opinion (314)
Ovarian cancer (136)
Pain (168)
Pancreatic cancer (173)
Parkinson's disease (243)
Partnered (30)
Patents (423)
Patient recruitment (323)
Peanut (57)
People (66295)
Pharmaceutical (145)
Pharmacy benefit managers (27)
Phase I (23320)
Phase II (32822)
Phase III (24729)
Pipeline (2755)
Policy (295)
Postmarket research (3554)
Preclinical (10517)
Press Release (72)
Prostate cancer (202)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (684)
Real estate (7422)
Recruiting (79)
Regulatory (28050)
Reports (65)
Research institute (2692)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (75)
Schizophrenia (137)
Series A (211)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (96)
The Weekly (110)
Vaccines (1055)
Venture capital (67)
Weight loss (397)
Women's health (59)
Worklife (21)
Date
Today (4)
Last 7 days (727)
Last 30 days (2548)
Last 365 days (33424)
2025 (27010)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (304)
Arkansas (14)
Asia (51005)
Australia (8963)
California (9570)
Canada (2887)
China (914)
Colorado (405)
Connecticut (427)
Delaware (271)
Europe (117184)
Florida (1407)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (816)
India (52)
Indiana (466)
Iowa (20)
Japan (328)
Kansas (125)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1289)
Massachusetts (7182)
Michigan (315)
Minnesota (566)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2653)
New Mexico (32)
New York (2600)
North Carolina (1421)
North Dakota (10)
Northern California (4350)
Ohio (300)
Oklahoma (22)
Oregon (50)
Pennsylvania (1987)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3653)
Tennessee (150)
Texas (1503)
United States (35311)
Utah (284)
Virginia (250)
Washington D.C. (84)
Washington State (824)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,474 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ALS
Coya Exec Daniel Barvin Is on a Mission To End Genetic ALS and FTD
The
BioSpace
40 Under 40 winner
opens up about his very personal career transformation from wealth management to biotech—and what it’s like to develop a drug for amyotrophic lateral sclerosis and frontotemporal dementia as a potential patient himself.
October 27, 2025
·
5 min read
·
Heather McKenzie
Huntington’s disease
4 Huntington’s Therapies Chasing UniQure
Last month, “historic positive results” from uniQure’s gene therapy snapped the Huntington’s community out of years of failure. As the biotech prepares to submit for FDA approval,
BioSpace
looks at four more candidates on the near horizon.
October 27, 2025
·
6 min read
·
Heather McKenzie
Huntington’s disease
UniQure’s Huntington’s Breakthrough Brings Hope to Patients but Experts Urge Caution
Pivotal results from uniQure’s gene therapy for Huntington’s disease have brought new light to patients who have known only disappointment in recent years—but one expert worries that communication of the results is creating “false expectations.”
October 27, 2025
·
6 min read
·
Heather McKenzie
M&A
Novartis To ‘Bolster’ Neuromuscular Pipeline With $12B Avidity Acquisition
The deal, announced early Sunday afternoon, will see Novartis gain access to Avidity’s neuroscience assets, while the San Diego biotech spins out a new company to shepherd its early-stage precision cardiology programs.
October 26, 2025
·
2 min read
·
Heather McKenzie
Ohio Life Sciences
Missouri Biotechnology Association (MOBIO)
Illinois Biotechnology Industry Organization (iBIO)
Esperion Therapeutics Inc.
BioForward (WI)
MichBio
1 of 86,148
Next
